Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow
Tevogen Bio腫瘤報告首次銷售年度營業收入預測爲10億美元，累計5年預估爲100億至140億美元；非腫瘤治療領域的預測將隨後而來
